| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |